pirinixic acid has been researched along with Neoplasms in 3 studies
pirinixic acid: structure
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "in inflammation, neurodegeneration and cancer seem very promising." | 2.55 | Therapeutic applications of the versatile fatty acid mimetic WY14643. ( Merk, D; Pollinger, J, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willson, TM | 1 |
| Brown, PJ | 1 |
| Sternbach, DD | 1 |
| Henke, BR | 1 |
| Pollinger, J | 1 |
| Merk, D | 1 |
| Verma, M | 1 |
| Martin, HJ | 1 |
| Haq, W | 1 |
| O'Connor, TR | 1 |
| Maser, E | 1 |
| Balendiran, GK | 1 |
2 reviews available for pirinixic acid and Neoplasms
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligand | 2000 |
Therapeutic applications of the versatile fatty acid mimetic WY14643.
Topics: Animals; Anticholesteremic Agents; Drug Design; Fatty Acids; Humans; Inflammation; Molecular Targete | 2017 |
1 other study available for pirinixic acid and Neoplasms
| Article | Year |
|---|---|
Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzot | 2008 |